AnaptysBio Inc buy Piper Sandler
Start price
16.02.24
/
50%
€22.00
Target price
16.02.25
€74.42
Performance (%)
-7.27%
End price
17.02.25
€20.40
Summary
This prediction ended on 17.02.25 with a price of €20.40. With a performance of -7.27%, the BUY prediction for AnaptysBio Inc by Piper_Sandler closed slightly in the red. Piper_Sandler has a follow-up prediction for AnaptysBio Inc where he still thinks AnaptysBio Inc is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AnaptysBio Inc | -20.319% | -20.319% | 149.667% |
| iShares Core DAX® | -0,20 % | 5,47 % | 9,19 % |
| iShares Nasdaq 100 | 2,57 % | 10,09 % | 39,29 % |
| iShares Nikkei 225® | 0,60 % | 9,87 % | 46,20 % |
| iShares S&P 500 | 1,80 % | 7,40 % | 29,62 % |
Comments by Piper_Sandler for this prediction
In the thread AnaptysBio Inc diskutieren
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $80.00 price target on the stock.
Ratings data for ANAB provided by MarketBeat
In the thread Trading AnaptysBio Inc
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten